SCHEMBL8384689

SCHEMBL8384689

CC(C)(C)c1ccc(P(O)O)cc1

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 1/20 0.52
TYR P14679 1/20 0.52
TSHR P16473 1/20 0.48
HDAC1 Q13547 1/20 0.41
SLC22A2 O15244 1/20 0.41
SLC22A1 O15245 1/20 0.41
SLC22A3 O75751 1/20 0.41
ALDH1A1 P00352 2/20 0.41
HPGD P15428 1/20 0.41
ALOX15 P16050 1/20 0.41
HSD17B10 Q99714 1/20 0.41
TDP1 Q9NUW8 1/20 0.41
SRD5A2 P31213 1/20 0.40
KIF11 P52732 2/20 0.39
NPC1 O15118 2/20 0.39
RAB9A P51151 2/20 0.39
SMN1; SMN2 Q16637 2/20 0.39
MEN1 O00255 1/20 0.39
MAPT P10636 1/20 0.39
XBP1 P17861 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1093877 0.78 TSHR (0.52) LMNATYRTSHRHDAC1SLC22A2
Hydrogen Peroxide SCHEMBL28677809 0.76 LMNA (0.71) LMNATYRTSHRHDAC1SLC22A2
SCHEMBL424728 0.76 TSHR (0.73) LMNATYRTSHRHDAC1SLC22A2
SCHEMBL9818511 0.76 ESR1 (0.32)
SCHEMBL13454805 0.76 TSHR (0.50) LMNATYRTSHRHDAC1SLC22A2
SCHEMBL2886665 0.74 TSHR (0.48) LMNATYRTSHRHDAC1SLC22A2
SCHEMBL1305145 0.74 TSHR (0.48) LMNATYRTSHRHDAC1SLC22A2
SCHEMBL2154563 0.74 TSHR (0.48) LMNATYRTSHRHDAC1SLC22A2
SCHEMBL1304647 0.74 TSHR (0.48) LMNATYRTSHRHDAC1SLC22A2
SCHEMBL28464951 0.74 LMNA (0.84) LMNATYRTSHRALDH1A1HPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7960392-B2 Nitrogen-containing heterocyclic compounds ASAHI KASEI PHARMA CORPORATION (JP) 2011-06-14 US disclosed
US-20100029690-A1 NITROGEN-CONTAINING HETEROCYCLIC COMPOUNDS ASAHI KASEI PHARMA CORPORATION (JP) 2010-02-04 US disclosed
EP-0487343-B1 Process for preparing a lithographic plate FUJI PHOTO FILM CO LTD (JP) 1999-04-28 EP disclosed
EP-0487343-A1 Process for preparing a lithographic plate Fuji Photo Film Co., Ltd. (JP) 1992-05-27 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100029690-A1 NITROGEN-CONTAINING HETEROCYCLIC COMPOUNDS PTGER1, PTGS1, PTGER2 LMNA 3415/4885TYR 3067/4885TSHR 4030/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.